{"id":45621,"date":"2022-06-29T12:01:24","date_gmt":"2022-06-29T10:01:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/"},"modified":"2022-06-29T12:01:24","modified_gmt":"2022-06-29T10:01:24","slug":"the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/","title":{"rendered":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5602688\/pharmaceutical-contract-development-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nk3qsw&amp;utm_campaign=1719683+-+The+Worldwide+Pharmaceutical+Contract+Development+%26+Manufacturing+Industry+is+Expected+to+Reach+%24226+Billion+by+2029&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Pharmaceutical Contract Development &amp; Manufacturing Market by Service, End User &#8211; Global Forecast to 2029&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Pharmaceutical Contract Development and Manufacturing Market is expected to grow at a CAGR of 7.5% from 2022 to 2029 to reach $226.35 billion by 2029.\n<\/p>\n<p>\nFollowing extensive secondary and primary research and an in-depth analysis of the market scenario, the report presents key industry drivers, restraints, challenges, and opportunities. The growth of the pharmaceutical contract development and manufacturing market is mainly attributed to complex manufacturing requirements, patent expiration, increasing investments in pharmaceutical R&amp;D, the pharmaceutical industry&#8217;s inclination towards cutting-edge technologies, and the outbreak of the coronavirus pandemic.\n<\/p>\n<p>\nMoreover, the growing demand for cell and gene therapies and personalized medicines and the growth of the High-potency Active Pharmaceutical Ingredients (HPAPI) and Antibody-drug Conjugates (ADC) markets offer significant opportunities for the players operating in the pharmaceutical contract development and manufacturing market.\n<\/p>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\n<em><strong>Drivers<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nComplex Manufacturing Requirements of the Pharmaceutical industry and Manufacturers&#8217; Growing inclination Toward the Use of Cutting-Edge Technologies\n<\/li>\n<li>\nRising Demand for Generic Medicines and Biologics\n<\/li>\n<li>\nPatent Expiration\n<\/li>\n<li>\nIncreasing Investments in Pharmaceutical R&amp;D\n<\/li>\n<li>\nOutbreak of the COVID-19 Pandemic\n<\/li>\n<\/ul>\n<p>\n<em><strong>Challenges<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nShortage of Skilled Professionals\n<\/li>\n<li>\nIntroduction of Serialization\n<\/li>\n<\/ul>\n<p>\n<em><strong>Opportunities<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nGrowing Demand for Cell Therapies, Gene Therapies, and Personalized Medicines\n<\/li>\n<li>\nGrowth in High Potency Active Pharmaceutical Ingredients (HPAPI) and Antibody-drug Conjugates (ADC) Markets\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nThermo Fisher Scientific Inc. (U.S.)\n<\/li>\n<li>\nCatalent Inc. (U.S.)\n<\/li>\n<li>\nLonza Group Ltd (Switzerland)\n<\/li>\n<li>\nRecipharm AB (Sweden)\n<\/li>\n<li>\nVetter Pharma International GmbH (Germany)\n<\/li>\n<li>\nPiramal Enterprises Limited (India)\n<\/li>\n<li>\nAlmac Group (U.K.)\n<\/li>\n<li>\nCambrex Corporation (U.S.)\n<\/li>\n<li>\nSamsung Biologics Co. Ltd (South Korea)\n<\/li>\n<li>\nSiegfried Holding AG (Switzerland)\n<\/li>\n<li>\nFUJIFILM Diosynth Biotechnologies (Japan)\n<\/li>\n<li>\nAenova Group (Germany)\n<\/li>\n<li>\nC.H. Boehringer Sohn AG &amp; Co. KG (Germany)\n<\/li>\n<li>\nFareva SA (Luxembourg)\n<\/li>\n<li>\nFabbrica Italiana Sintetici S.p.A. (Italy)\n<\/li>\n<li>\nWuXi Biologics (Cayman) Inc. (China)\n<\/li>\n<li>\nAurobindo Pharma Ltd. (India)\n<\/li>\n<\/ul>\n<p>\n<strong>Scope of the Report:<\/strong>\n<\/p>\n<p>\n<strong>Pharmaceutical Contract Development and Manufacturing Market, by Service<\/strong>\n<\/p>\n<ul>\n<li>\nPharmaceutical Manufacturing Services\n<\/li>\n<li>\nPharmaceutical API Manufacturing Services\n<\/li>\n<li>\nPharmaceutical FDF Manufacturing Services\n<\/li>\n<li>\nParenteral\/Injectable Manufacturing Services\n<\/li>\n<li>\nTablet Manufacturing Services\n<\/li>\n<li>\nCapsule Manufacturing Services\n<\/li>\n<li>\nOral Liquid Manufacturing Services\n<\/li>\n<li>\nOther Formulations Manufacturing Services\n<\/li>\n<li>\nDrug Development Services\n<\/li>\n<li>\nBiologics Manufacturing Services\n<\/li>\n<li>\nBiologics API Manufacturing Services\n<\/li>\n<li>\nBiologics FDF Manufacturing Services\n<\/li>\n<li>\nPackaging Services\n<\/li>\n<\/ul>\n<p>\n<strong>Pharmaceutical Contract Development and Manufacturing Market, by End User<\/strong>\n<\/p>\n<ul>\n<li>\nLarge Pharmaceutical Companies\n<\/li>\n<li>\nSmall and Mid-size Pharmaceutical Companies\n<\/li>\n<li>\nGeneric Pharmaceutical Companies\n<\/li>\n<\/ul>\n<p>\n<strong>Pharmaceutical Contract Development and Manufacturing Market, by Geography<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nU.K.\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nSwitzerland\n<\/li>\n<li>\nRest of Europe (RoE)\n<\/li>\n<li>\nAsia-Pacific (APAC)\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nRest of APAC (RoAPAC)\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nRest of Latin America\n<\/li>\n<li>\nMiddle East &amp; Africa\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5602688\/pharmaceutical-contract-development-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nk3qsw&amp;utm_campaign=1719683+-+The+Worldwide+Pharmaceutical+Contract+Development+%26+Manufacturing+Industry+is+Expected+to+Reach+%24226+Billion+by+2029&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/2pij4z<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x70;r&#101;&#115;&#x73;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;&#x68;a&#110;&#100;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#101;&#x73;&#x73;&#64;&#114;&#101;&#x73;&#x65;&#x61;r&#99;&#104;&#x61;&#x6e;dm&#97;&#x72;&#x6b;&#x65;t&#115;&#46;&#x63;&#x6f;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharmaceutical Contract Development &amp; Manufacturing Market by Service, End User &#8211; Global Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Pharmaceutical Contract Development and Manufacturing Market is expected to grow at a CAGR of 7.5% from 2022 to 2029 to reach $226.35 billion by 2029. Following extensive secondary and primary &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45621","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharmaceutical Contract Development &amp; Manufacturing Market by Service, End User &#8211; Global Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Pharmaceutical Contract Development and Manufacturing Market is expected to grow at a CAGR of 7.5% from 2022 to 2029 to reach $226.35 billion by 2029. Following extensive secondary and primary ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T10:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-29T10:01:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/\"},\"wordCount\":502,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005487\\\/en\\\/1500534\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/\",\"name\":\"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005487\\\/en\\\/1500534\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-29T10:01:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005487\\\/en\\\/1500534\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005487\\\/en\\\/1500534\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pharmaceutical Contract Development &amp; Manufacturing Market by Service, End User &#8211; Global Forecast to 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Pharmaceutical Contract Development and Manufacturing Market is expected to grow at a CAGR of 7.5% from 2022 to 2029 to reach $226.35 billion by 2029. Following extensive secondary and primary ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T10:01:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-29T10:01:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/"},"wordCount":502,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/","name":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg","datePublished":"2022-06-29T10:01:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220629005487\/en\/1500534\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-pharmaceutical-contract-development-manufacturing-industry-is-expected-to-reach-226-billion-by-2029-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Worldwide Pharmaceutical Contract Development &amp; Manufacturing Industry is Expected to Reach $226 Billion by 2029 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45621"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45621\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}